Investigative Ophthalmology & Visual Science,
Journal Year:
2025,
Volume and Issue:
66(1), P. 50 - 50
Published: Jan. 22, 2025
Purpose:
The
purpose
of
this
study
was
to
investigate
the
activated
core
kinases
involved
in
DNA
damage
responses
(DDR)
during
ferroptosis
retinal
pigment
epithelial
(RPE)
cells
vitro
and
their
regulatory
effects
on
ferroptosis.
Methods:
Ferroptosis
induced
by
erastin
RPE
(iRPE)
derived
from
human
umbilical
cord
mesenchymal
stem
(hUCMSCs),
hUCMSCs,
pluripotent
cell-derived
(iPSC-RPE)
cells.
CCK8
employed
measure
cell
viability.
Calcein/PI
staining
used
detect
ferroptotic
γ-H2AX,
8-oxoG,
phosphorylated
DNA-dependent
protein
kinase
catalytic
subunit
(DNA-PKcs)
were
determined
through
immunostaining.
phosphorylation
DNA-PKcs
ERK1/2
Western
blotting.
Lipid
peroxides
detected
BODIPY581/591-C11
staining.
Results:
iRPE
exhibited
a
stronger
ability
resist
compared
hUCMSCs.
cells,
rapidly
treatment
erastin.
In
addition,
inhibition
promoted
suggesting
that
prevents
Meanwhile,
inhibited
only
at
early
stage
induction,
whereas
played
protective
role
Furthermore,
inducing
its
promoting
also
verified
iPSC-RPE
Conclusions:
present
elucidates
key
DDR
is
plays
vitro,
which
will
provide
new
research
targets
strategies
for
inhibiting
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 15, 2024
Low
selectivity
and
tumor
drug
resistance
are
the
main
hinderances
to
conventional
radiotherapy
chemotherapy
against
tumor.
Ion
interference
therapy
is
an
innovative
anti-tumor
strategy
that
has
been
recently
reported
induce
metabolic
disorders
inhibit
proliferation
of
cells
by
reordering
bioactive
ions
within
cells.
Calcium
cation
(Ca2+)
indispensable
for
all
physiological
activities
In
particular,
calcium
overload,
characterized
abnormal
intracellular
Ca2+
accumulation,
causes
irreversible
cell
death.
Consequently,
overload-based
ion
potential
overcome
traditional
treatment
strategies
holds
promise
clinical
application.
this
review,
we
1)
Summed
up
current
employed
in
therapy;
2)
Described
outcome
death
resulting
from
3)
Discussed
its
application
synergistic
with
immunotherapy.
Redox Biology,
Journal Year:
2022,
Volume and Issue:
59, P. 102582 - 102582
Published: Dec. 22, 2022
Obeticholic
acid
(OCA)
has
been
examined
to
treat
non-alcoholic
steatohepatitis
(NASH),
but
unsatisfactory
antifibrotic
effect
and
deficient
responsive
rate
in
recent
phase
III
clinical
trial.
Using
a
prolonged
western
diet-feeding
murine
NASH
model,
we
show
that
OCA-shaped
gut
microbiota
induces
lipid
peroxidation
impairs
its
anti-fibrotic
effect.
Mechanically,
Bacteroides
enriched
by
OCA
deconjugates
tauro-conjugated
bile
acids
generate
excessive
chenodeoxycholic
(CDCA),
resulting
liver
ROS
accumulation.
We
further
elucidate
reduces
triglycerides
containing
polyunsaturated
fatty
(PUFA-TGs)
levels,
whereas
elevates
free
PUFAs
phosphatidylethanolamines
PUFA
(PUFA-PEs),
which
are
susceptible
be
oxidized
peroxides
(notably
arachidonic
(ARA)-derived
12-HHTrE),
inducing
hepatocyte
ferroptosis
activating
hepatic
stellate
cells
(HSCs).
Inhibiting
with
pentoxifylline
(PTX)
rescues
of
OCA,
suggesting
combination
inhibitor
could
potential
pharmacological
approach
NASH-fibrosis.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
167, P. 115573 - 115573
Published: Sept. 26, 2023
Ovarian
cancer
(OC)
stands
as
the
second
most
prominent
factor
leading
to
cancer-related
fatalities,
characterized
by
a
notably
low
five-year
survival
rate.
The
insidious
onset
of
OC
combined
with
its
resistance
chemotherapy
poses
significant
challenges
in
terms
treatment,
emphasizing
utmost
importance
developing
innovative
therapeutic
agents.
Despite
remarkable
anti-tumor
efficacy,
celastrol
(CEL)
faces
regarding
clinical
utilization
due
restricted
water
solubility
and
notable
side
effects.
In
this
study,
was
encapsulated
into
Zeolitic
imidazolate
framework-8(ZIF-8)
nanoparticle
grafted
biotin-conjugated
polyethylene
glycol
(CEL@ZIF-8@PEG-BIO).
Comprehensive
comparisons
physicochemical
properties
anticancer
activities
CEL
CEL@ZIF-8@PEG-BIO
were
conducted.
Our
findings
revealed
that
exhibited
favorable
characteristics,
including
hydrodynamic
diameters
234.5
nm,
excellent
solubility,
high
drug
loading
(31.60%
±
2.85),
encapsulation
efficiency
(60.52%
2.79),
minimal
Furthermore,
can
release
chemicals
response
an
acidic
micro-environment,
which
is
more
likely
tumor
micro-environment.
vitro,
studies
showed
CEL@ZIF-8@BIO
inhibited
cell
proliferation,
led
mitochondrial
membrane
potential
(MMP)
decline,
generated
reactive
oxygen
species
cells.
Both
vitro
vivo
experiments
indicated
enhanced
activity
against
via
up-regulated
apoptosis-promoting
biomarkers
rendered
apoptosis
P38/JNK
MAPK
signaling
pathway.
conclusion,
we
have
successfully
developed
novel
delivery
system
(CEL@ZIF-8@PEG-BIO),
resulting
improvements
both
efficacy
thereby
providing
valuable
insights
for
future
development.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(5), P. 2215 - 2233
Published: Feb. 27, 2024
Abstract
Osteosarcoma
is
a
common
malignant
bone
tumour
characterised
by
an
aggressive
metastatic
potential.
The
microenvironment,
particularly
the
M2‐polarised
macrophages,
crucial
for
progression.
Cucurbitacin
B
(CuB),
triterpenoid
derivative,
recognised
its
anti‐inflammatory
and
antitumour
properties.
This
study
investigates
CuB
effect
on
M2
macrophage
differentiation
osteosarcoma
progression,
aiming
to
contribute
new
treatment
strategies.
In
vitro,
THP‐1
monocytes
were
stimulated
with
PMA,
IL‐13
IL‐4
induce
into
macrophages.
Additionally,
influence
of
proliferation,
migration
invasion
cells
in
context
macrophages
was
scrutinised.
Crucial
signalling
pathways,
especially
PI3K/AKT
pathway,
affected
identified
validated.
vivo,
model
employed
gauge
effects
weight,
lung
metastasis,
angiogenesis,
cell
proliferation
markers.
results
showed
that
inhibited
differentiation,
leading
reduced
cells.
manifested
inhibitory
pathway
during
mouse
models,
markedly
weight
number
metastases.
It
also
expression
angiogenesis
markers
tissues,
decreased
quantity
their
associated
proteins.
conclusion,
impedes
progression
inhibiting
via
presenting
potential
therapeutic
advancements
treatment.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 3, 2024
The
human
gut
microbiota
is
a
complex
ecosystem
that
plays
crucial
role
in
promoting
the
interaction
between
body
and
its
environment.
It
has
been
increasingly
recognized
diverse
physiological
functions.
Recent
studies
have
shown
close
association
development
of
certain
tumors,
including
leukemia.
Leukemia
malignant
clonal
disease
characterized
by
uncontrolled
growth
one
or
more
types
blood
cells,
which
most
common
cancer
children.
imbalance
linked
to
pathological
mechanisms
Probiotics,
are
beneficial
microorganisms
help
maintain
balance
host
microbiome,
play
regulating
microbiota.
Probiotics
potential
assist
treatment
leukemia
improve
clinical
prognosis
patients.
This
study
reviews
relationship
microbiota,
probiotics,
progression
based
on
current
research.
In
addition,
utilizing
zebrafish
models
future
might
reveal
specific
their
interactions,
thereby
providing
new
insights
into
conclusion,
further
investigation
still
needed
fully
understand
accurate
microbes
QJM,
Journal Year:
2023,
Volume and Issue:
116(6), P. 421 - 428
Published: March 25, 2023
Previous
studies
have
reported
inconsistent
results
on
the
association
between
circulating
lipids
and
lipid-lowering
drugs
with
risk
of
epilepsy.To
assess
whether
genetically
predicted
are
causally
associated
epilepsy
outcome.We
performed
a
two-sample
Mendelian
randomization
(MR)
analysis
model
to
predict
causal
effects
(apolipoprotein
A
[APOA],
apolipoprotein
B
[APOB],
cholesterol,
high-density
lipoprotein
cholesterol
[HDL-C],
low-density
[LDL-C],
triglycerides)
(HMG-CoA
reductase
[HMGCR]
proprotein
convertase
subtilisin/kexin
type
9
[PCSK9]
inhibitors)
epilepsy.
Nine
MR
methods
were
conducted
analyze
final
results.
The
inverse-variance
weighted
(IVW)
method
was
used
as
primary
outcome.
other
(simple
mode,
simple
median,
penalized
Egger
MR-Egger
[bootstrap])
complement
IVW.
In
addition,
robustness
assessed
by
leave-one-out
analysis.The
IVW
demonstrated
that
there
is
no
(APOA:
odds
ratio
[OR],
0.958,
95%
confidence
interval
(CI),
0.728-1.261,
P
=
0.760;
APOB:
OR,
1.092;
CI,
0.979-1.219,
0.115;
cholesterol:
1.210;
0.981-1.494,
0.077;
HDL-C:
0.964;
0.767-1.212,
0.753;
LDL-C:
1.100;
0.970-1.248,
0.137;
A:
1.082;
0.849-1.379,
0.528;
triglycerides:
1.126;
0.932-1.360,
0.221)
(HMGCR
inhibitors:
0.221;
0.006-8.408,
0.878;
PCSK9
1.112;
0.215-5.761,
0.902)
further
sensitivity
confirmed
results.This
study
relationships